1.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: SWOG-S0003, S0003, NCT00006484
|
|
2.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: SANOFI-EFC3675, NCT00017459
|
|
3.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: EFC4690, SR259075, NCT00094081
|
|
4.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: EFC5512, SR259075, NCT00174837
|
|
5.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2009-00591, U10CA027469, CDR0000455555, GOG-0219, CAN-NCIC-GOG-0219, NCT00262821
|
|
6.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: MSKCC-94082, NCI-V94-0542
|
|
7.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: MSKCC-96062, SANOFI-EFC3031, NCI-G97-1235
|
|
8.
|
Phase: Phase II Type: Treatment Status: Completed Age: over 18 Sponsor: NCI Protocol IDs: RTOG-9417, RTOG-94-17
|
|
9.
|
Phase: Phase II Type: Treatment Status: Closed Age: over 18 Sponsor: Pharmaceutical / Industry Protocol IDs: MSKCC-94114A1, NCI-V95-0659
|
|
10.
|
Phase: Phase II Type: Treatment Status: Completed Age: over 17 Sponsor: NCI Protocol IDs: SUMC-OP-003, NCI-T94-0119O, NCT00002774, T94-0119
|
|
11.
|
Phase: Phase II Type: Treatment Status: Completed Age: Not specified Sponsor: NCI Protocol IDs: GOG-0146M, NCT00020696
|
|
12.
|
Phase: Phase II Type: Treatment Status: Completed Age: Under 21 at time of initial diagnosis Sponsor: NCI Protocol IDs: COG-ARST0121, NCT00025363, ARST0121
|
|
13.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000318805, S0222, U10CA032102, SWOG-S0222, NCT00066742
|
|
14.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000066358, SWOG-S9717, U10CA032102, S9717, NCT00003369
|
|
15.
|
Phase: Phase I Type: Treatment Status: Closed Age: 21 and under Sponsor: NCI Protocol IDs: POG-9675, NCT00003288
|
|
16.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: 99139, U01CA062505, P30CA033572, CHNMC-PHI-22, CHNMC-IRB-99139, NCI-T99-0068, CDR0000067685, T99-0068, NCT00005078
|
|
17.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000068318, U10CA032102, SWOG-S0004, S0004, NCT00006487
|
|
18.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: CCC-PHI-31, CHNMC-PHI-31, NCI-571, NCT00033410, 571
|
|
19.
|
Phase: Phase I Type: Treatment Status: Completed Age: Any age Sponsor: NCI Protocol IDs: PMCC-2004/354, 5485, NCI-5485, NCT00098995
|